Top Markets
#1 Pleasing Gold Pleasing Gold +1,543.14%
#2 PulseChain PulseChain +57.40%
#3 Ontology Gas Ontology Gas +36.19%
#4 Merlin's Seal BTC Merlin's Seal BTC +31.77%
#5 BOOK OF MEME BOOK OF MEME +30.30%
#6 Collect on Fanable Collect on Fanable +24.02%
#7 Neiro Neiro +20.79%
#8 Unit Pump Unit Pump +20.03%
#9 Pump.fun Pump.fun +20.03%
#10 Nockchain Nockchain +19.80%
Coin of the day
Pleasing Gold Pleasing Gold
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Rangering i aksjer #26679
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Aksjekurs
$3.49
Sist synkronisert: 2023-12-19
Markedsverdi
$38.68M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Neoleukin Therapeutics, Inc. (NLTX)

Kategori

Healthcare
P/B-forhold for Neoleukin Therapeutics, Inc. (NLTX)
P/B-forhold per 2026 TTM: 0
Ifølge Neoleukin Therapeutics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Neoleukin Therapeutics, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.5207 -
IN